| Architectural protein subclasses shape 3D organization of genomes during lineage commitment JE Phillips-Cremins, MEG Sauria, A Sanyal, TI Gerasimova, BR Lajoie, ... Cell 153 (6), 1281-1295, 2013 | 1251 | 2013 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 470* | 2021 |
| Dynamic responses of Bacteroides thetaiotaomicron during growth on glycan mixtures TE Rogers, NA Pudlo, NM Koropatkin, JSK Bell, M Moya Balasch, ... Molecular microbiology 88 (5), 876-890, 2013 | 138 | 2013 |
| Structural basis for KDM5A histone lysine demethylase inhibition by diverse compounds JR Horton, X Liu, M Gale, L Wu, JR Shanks, X Zhang, PJ Webber, ... Cell chemical biology 23 (7), 769-781, 2016 | 94 | 2016 |
| Orphan CpG islands define a novel class of highly active enhancers JSK Bell, PM Vertino Epigenetics 12 (6), 449-464, 2017 | 55 | 2017 |
| Epigenetically heterogeneous tumor cells direct collective invasion through filopodia-driven fibronectin micropatterning ER Summerbell, JK Mouw, JSK Bell, CM Knippler, B Pedro, JL Arnst, ... Science Advances 6 (30), eaaz6197, 2020 | 48 | 2020 |
| Galactic cosmic radiation induces persistent epigenome alterations relevant to human lung cancer EM Kennedy, DR Powell, Z Li, JSK Bell, BG Barwick, H Feng, ... Scientific reports 8 (1), 6709, 2018 | 35 | 2018 |
| GC skew defines distinct RNA polymerase pause sites in CpG island promoters WA Kellner, JSK Bell, PM Vertino Genome research 25 (11), 1600-1609, 2015 | 26 | 2015 |
| Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort BD Leibowitz, BV Dougherty, JSK Bell, J Kapilivsky, J Michuda, ... BMC cancer 22 (1), 587, 2022 | 24 | 2022 |
| Racial disparities in pathological complete response among patients receiving neoadjuvant chemotherapy for early-stage breast cancer F Zhao, M Miyashita, M Hattori, T Yoshimatsu, F Howard, K Kaneva, ... JAMA network open 6 (3), e233329-e233329, 2023 | 12 | 2023 |
| Systems and methods for multi-label cancer classification J Michuda, KA Beauchamp, J Kapilivsky, C McCarter, N Beaubier, ... US Patent 11,527,323, 2022 | 12 | 2022 |
| Real-world evidence of diagnostic testing and treatment patterns in US patients with breast cancer with implications for treatment biomarkers from RNA sequencing data LE Fernandes, CG Epstein, AM Bobe, JSK Bell, MC Stumpe, ME Salazar, ... Clinical Breast Cancer 21 (4), e340-e361, 2021 | 12 | 2021 |
| Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African … M Miyashita, JSK Bell, S Wenric, E Karaesmen, B Rhead, M Kase, ... Breast Cancer Research 25 (1), 58, 2023 | 11 | 2023 |
| Factors affecting the persistence of drug-induced reprogramming of the cancer methylome JSK Bell, JD Kagey, BG Barwick, B Dwivedi, MT McCabe, J Kowalski, ... Epigenetics 11 (4), 273-287, 2016 | 11 | 2016 |
| Neratinib+ fulvestrant+ trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial K Jhaveri, LD Eli, H Wildiers, SA Hurvitz, A Guerrero-Zotano, N Unni, ... Annals of Oncology 34 (10), 885-898, 2023 | 9 | 2023 |
| Systems and methods for multi-label cancer classification J Michuda, KA Beauchamp, J Kapilivsky, C McCarter, N Beaubier, ... US Patent App. 17/150,992, 2021 | 8 | 2021 |
| Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet Diabetes & Endocrinology 11 (12), 905-914, 2023 | 6 | 2023 |
| Transcriptome-based cancer type prediction for tumors of unknown origin. J Michuda, C Igartua, T Taxter, JSK Bell, R Pelossof, K White Journal of Clinical Oncology 37 (15_suppl), 3081-3081, 2019 | 6 | 2019 |
| Comprehensive validation of RNA sequencing for clinical NGS fusion genes and RNA expression reporting J Hu, J Parsons, B Mineo, JSK Bell, J Malinauskas, J Drews, J Michuda, ... Cancer Res 81 (13 Supplement), 2239, 2021 | 4 | 2021 |
| Integrated machine-learning framework to estimate homologous recombination deficiency A Venkat, J Parsons, JSK Bell, C Igartua, Y Zhang, A Salahudeen, ... US Patent 10,975,445, 2021 | 3 | 2021 |
